Skip to Content

DA-032 15 (Abilify MyCite 15 mg)

Generic Name: aripiprazole

Pill with imprint DA-032 15 is Yellow, Round and has been identified as Abilify MyCite 15 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-032 15

Abilify MyCite

Generic Name:
aripiprazole
Imprint:
DA-032 15
Strength:
15 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC):
59148-0032

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide